Show simple item record

dc.contributor.authorStarosta, Rodrigo Tzovenospt_BR
dc.contributor.authorVidor, Marcos Viníciuspt_BR
dc.contributor.authorRizzi, Liarapt_BR
dc.contributor.authorMarques, Fabricio Correiapt_BR
dc.contributor.authorRoriz-Cruz, Matheuspt_BR
dc.date.accessioned2020-12-18T04:13:18Zpt_BR
dc.date.issued2016pt_BR
dc.identifier.issn2399-9624pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/216688pt_BR
dc.description.abstractUraemia is a state of elevated plasma urea well related to a low cognitive profile. Although renal transplantation has been proved to improve cognition in these patients, little is known about how haemodialysis act on this scenario. Here we aimed to conduct a pilot study to fathom the presence and magnitude of a possible benefit of haemodialysis in cognition. Our main instrument was the Montreal Cognitive Assessment (MoCA) test, a tool designed to allow for a sensitive score for cognitive impairment. Although preliminary, our data were significant (p=0.012) to suggest that haemodialysis might be an important tool for cognitive improvement of end-stage kidney disease patients, tough not sufficient for a full cognitive recovery.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofAlzheimer's, Dementia & Cognitive Neurology. Londres. Vol. 1, no. 1 (2016), p. 1-3pt_BR
dc.rightsOpen Accessen
dc.subjectDiálise renalpt_BR
dc.subjectUremiapt_BR
dc.subjectCogniçãopt_BR
dc.subjectFalência renal crônicapt_BR
dc.titleHaemodialysis improves uraemic patients' cognition : a pilot studypt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001046569pt_BR
dc.type.originEstrangeiropt_BR


Files in this item

Thumbnail
   

This item is licensed under a Creative Commons License

Show simple item record